| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Transplant Center, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA
Posttransplant infusion of donor bone marrow cells (BMC) induces tolerance to allografts in adult mice, dogs, nonhuman primates, and probably humans. Here we used a mouse skin allograft model and an allogeneic radiation chimera model to examine the role of MHC Ags in tolerance induction. Infusion of MHC class II Ag-deficient (CIID) BMC failed to prolong C57BL/6 (B6) skin grafts in ALS- and rapamycin-treated B10.A mice, whereas wild-type B6 or MHC class I Ag-deficient BMC induced prolongation. Removal of class II Ag-bearing cells from donor BMC markedly reduced the tolerogenic effect compared with untreated BMC, although graft survival was significantly longer in mice given depleted BMC than that in control mice given no BMC. Infusion of CIID BMC into irradiated syngeneic B6 or allogeneic B10.A mice produced normal lymphoid cell reconstitution including CD4+ T cells except for the absence of class II Ag-positive cells. However, irradiated B10.A mice reconstituted with CIID BMC rejected all B6 and a majority of CIID skin grafts despite continued maintenance of high degree chimerism. B10.A mice reconstituted with B6 BMC maintained chimerism and accepted both B6 and CIID skin grafts. Thus, expression of MHC class II Ag on BMC is essential for allograft tolerance induction and peripheral chimerism with cells deficient in class II Ag does not guarantee allograft acceptance.
This article has been cited by other articles:
|
|
 |
|
  F. Casiraghi, N. Azzollini, P. Cassis, B. Imberti, M. Morigi, D. Cugini, R. A. Cavinato, M. Todeschini, S. Solini, A. Sonzogni, et al. Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells J. Immunol., September 15, 2008; 181(6): 3933 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Priddle, D. R. E. Jones, P. W. Burridge, and R. Patient Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies Stem Cells, April 1, 2006; 24(4): 815 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kanamoto and T. Maki Chimeric Donor Cells Play an Active Role in Both Induction and Maintenance Phases of Transplantation Tolerance Induced by Mixed Chimerism J. Immunol., February 1, 2004; 172(3): 1444 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, P. M. Chilton, Y. Huang, C. L. Schanie, and S. T. Ildstad Production of Donor T Cells Is Critical for Induction of Donor-Specific Tolerance and Maintenance of Chimerism J. Immunol., February 1, 2004; 172(3): 1463 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Abe, J. Qi, M. Sykes, and Y.-G. Yang Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier Blood, May 15, 2002; 99(10): 3823 - 3829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noris, D. Cugini, F. Casiraghi, N. Azzollini, L. D. D. V. Moraes, M. Mister, A. Pezzotta, R. A. Cavinato, S. Aiello, N. Perico, et al. Thymic Microchimerism Correlates with the Outcome of Tolerance-Inducing Protocols for Solid Organ Transplantation J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2815 - 2826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Umemura, H. Morita, X. Chang Li, S. Tahan, A. P. Monaco, and T. Maki Dissociation of Hemopoietic Chimerism and Allograft Tolerance After Allogeneic Bone Marrow Transplantation J. Immunol., September 15, 2001; 167(6): 3043 - 3048. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
